Literature DB >> 22783707

Opioids and protection against ischemia-reperfusion injury: from experimental data to potential clinical applications.

G Minguet1, J F Brichant, J Joris.   

Abstract

Ischemic preconditioning, first demonstrated in animal myocardium, is an intrinsic and ubiquitous mechanism of marked protection against ischemia. Accumulating evidences have established that endogenous opioid peptides and their receptors play an important role in this adaptive phenomenon in the heart and other major organs. Of interest for therapeutic developments, opioid receptor agonists have been administered successfully to improve tolerance against experimental ischemia-reperfusion in various tissues. Recent human studies now raise the possibility to exploit this opioid-induced protection in clinical cardiac ischemia. These remarkable anti-ischemic properties of opioids and their emerging potential for organ protection in perioperative medicine will be reviewed at the light of pertinent results from basic and clinical researches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783707

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  8 in total

1.  [Effect of dexmedetomidine postconditioning on myocardial ischemia-reperfusion injury and inflammatory response in diabetic rats].

Authors:  Jing Hu; Xiao-Yu Gu; Yan Meng; Ya Wang; Qin Gao; Zheng-Hong Li; Xiao-Hong Li; Xiang-Yang Cheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

2.  Featured Article: Pharmacological postconditioning with delta opioid attenuates myocardial reperfusion injury in isolated porcine hearts.

Authors:  Maria Seewald; James A Coles; Daniel C Sigg; Paul A Iaizzo
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

3.  Effect of dexmedetomidine on myocardial ischemia-reperfusion injury.

Authors:  Shoulin Chen; Fuzhou Hua; Jun Lu; Yu Jiang; Yanhua Tang; Lei Tao; Bing Zou; Qinghua Wu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Potential of caveolae in the therapy of cardiovascular and neurological diseases.

Authors:  Gemma Navarro; Dasiel O Borroto-Escuela; Kjell Fuxe; Rafael Franco
Journal:  Front Physiol       Date:  2014-09-30       Impact factor: 4.566

5.  Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?

Authors:  E Erkılıç; E Kesimci; F Alaybeyoğlu; I Kılınç; R Tural; A Yazgan; T Gümüş; A Sepici Dinçel; E G Dumlu; O Kanbak
Journal:  Drug Des Devel Ther       Date:  2017-03-08       Impact factor: 4.162

6.  The effects of tramadol on hepatic ischemia/reperfusion injury in rats.

Authors:  Mona F Mahmoud; Samar Gamal; Mohamed A Shaheen; Hassan M El-Fayoumi
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

7.  The effect of dexmedetomidine and remifentanil on the postoperative sore throat after thyroidectomy.

Authors:  Hyuckgoo Kim; Hyojin Kwon; Sungmin Jeon; Eun Kyung Choi
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

8.  Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.

Authors:  Jinjie Li; Ying Zhao; Nan Zhou; Longyun Li; Kai Li
Journal:  J Diabetes Res       Date:  2019-11-30       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.